REQUEST A DEMO
Total
USD $0.00
Search more companies

Isomed Pharma Colombia S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Isomed Pharma Colombia S.A.S. Profile Updated: April 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Isomed Pharma Colombia S.A.S. is an enterprise based in Colombia. Its main office is in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on May 04, 2016. The total number of employees is currently 9 (2026). From the latest financial highlights, Isomed Pharma Colombia S.A.S. reported a net sales revenue increase of 4.1% in 2025. There was a total negative growth of 4.79% in Isomed Pharma Colombia S.A.S.’s total assets over the same period. In 2025, Isomed Pharma Colombia S.A.S.’s net profit margin increased by 0.66%.

Headquarters
Cl 93 # 11 A - 28 Of 603
Bogota D.C.; Bogota D.C;

Contact Details: Purchase the Isomed Pharma Colombia S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Isomed Pharma Colombia S.A.S. report to view the information.
Financial Auditors:
Purchase the Isomed Pharma Colombia S.A.S. report to view the information.
Incorporation Date:
May 04, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Isomed Pharma Colombia S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
4.1%
Total Operating Revenue
4.1%
Operating Profit
16432.63%
Net Profit/Loss for the Period
179.69%
Total Assets
-4.79%
Total Equity
9.03%
Operating Profit Margin
61.42%
Net Profit Margin
0.66%
Return on Equity (ROE)
5.05%
Quick Ratio
10.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?